Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

IRadimed Corporation

IRMD

Valuace

30

Růst

100

Zdraví

80

Cena

$ 96.62

-0.57 (-0.56%)

Návštěvnost webu

Zprávy společnosti

Výsledovka

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Total Revenues		83.8	83.8	73.2	65.6	53.3	41.8	31.7	38.5	30.4	23.1	32.5	31.6	15.7	11.3	7.7
Cost of Revenues		19.5	19.5	16.9	15.4	12.0	9.8	8.1	8.8	7.2	5.6	6.2	5.8	3.4	2.9	2.1
Gross Profit		64.3	64.3	56.3	50.2	41.3	32.0	23.6	29.7	23.2	17.5	26.3	25.8	12.2	8.5	5.6

Revenue		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues		22.7	21.2	20.4	19.5	19.4	18.3	17.9	17.6	17.5	16.5
Cost of Revenues		5.7	4.7	4.5	4.7	4.6	4.1	3.9	4.2	4.0	3.7
Gross Profit		17.0	16.5	16.0	14.8	14.8	14.2	14.0	13.4	13.4	12.8

Operating Income		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
R&D Expenses		0.0	0.0	0.0	2.9	2.3	1.9	1.9	1.4	1.5	1.7	1.3	1.8	1.1	1.0	0.7
Selling General & Admin Expenses		0.0	0.0	0.0	27.3	23.4	20.3	22.4	19.6	15.7	14.5	14.1	12.5	8.1	4.7	3.5
Depreciation & Amortization		1.8	2.4	0.8	0.8	0.7	1.4	1.3	1.2	1.1	1.3	0.2	0.2	0.1	0.1	0.1
Total Operating Expenses		38.2	38.2	34.4	30.1	25.7	22.2	24.3	21.1	17.2	16.2	15.4	14.2	9.2	5.7	4.1
Operating Income		26.1	26.1	22.0	20.0	15.6	9.8	-0.8	8.6	6.0	1.3	10.9	11.5	3.1	2.8	1.4

Operating Income		TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5
Selling General & Admin Expenses		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.5
Depreciation & Amortization		0.6	0.4	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2
Total Operating Expenses		9.9	9.7	9.2	9.4	9.0	8.4	8.4	8.6	8.3	6.9
Operating Income		7.1	6.8	6.8	5.4	5.8	5.8	5.6	4.7	5.2	5.9

Net Income		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Interest Income		0.0	0.0	2.2	1.9	0.6	0.0	0.1	0.4	0.2	0.1	0.1	0.1	0.0	0.0	0.0
Interest Expense		0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Expense		2.2	2.2	2.3	1.7	0.6	0.0	0.1	0.4	0.2	0.1	0.0	0.1	0.0	0.0	0.0
IBT		28.4	28.4	24.3	21.7	16.2	9.8	-0.6	9.0	6.2	1.4	11.0	11.6	3.0	2.8	1.4
Income Tax Expense		5.9	5.9	5.0	4.5	3.4	0.5	-2.0	-0.6	-0.1	0.9	3.7	4.1	1.0	0.8	0.5
Net Income		22.5	22.5	19.2	17.2	12.8	9.3	1.4	9.6	6.3	0.5	7.2	7.5	2.1	1.9	1.0

Net Income		TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest Expense		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
Other Expense		0.7	0.5	0.5	0.5	0.5	0.6	0.6	0.5	0.5	0.5
IBT		7.8	7.3	7.3	5.9	6.3	6.4	6.3	5.2	5.7	6.4
Income Tax Expense		1.3	1.7	1.6	1.3	1.2	1.4	1.4	1.1	1.1	1.3
Net Income		6.4	5.6	5.8	4.7	5.1	5.0	4.9	4.1	4.5	5.1

Per Share Data		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
EPS		$0.00	$0.00	$0.00	$1.36	$1.02	$0.76	$0.11	$0.85	$0.59	$0.05	$0.67	$0.68	$0.23	$0.19	$0.09
EPS Diluted		$0.00	$0.00	$0.00	$1.35	$1.02	$0.74	$0.11	$0.78	$0.52	$0.04	$0.60	$0.60	$0.20	$0.19	$0.09
Shares Outstanding		12.7	12.7	12.7	12.6	12.6	12.3	12.1	11.3	10.8	10.6	10.8	11.0	8.7	10.4	10.4
Diluted Shares Outstanding		12.9	12.9	12.8	12.7	12.6	12.6	12.4	12.3	12.1	11.7	12.0	12.6	10.2	10.4	10.4

Per Share Data		TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS		$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.36	$0.40
EPS Diluted		$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.36	$0.40
Shares Outstanding		12.7	12.7	12.7	12.7	12.7	12.7	12.7	12.7	12.6	12.6
Diluted Shares Outstanding		12.9	12.9	12.8	12.8	12.8	12.8	12.8	12.7	12.7	12.7

Current Assets		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Cash And Equivalents		48.5	52.2	49.8	58.0	62.0	50.1	43.5	28.0	18.2	17.7	19.4	9.5	2.5	1.7
Short Term Investments		0.0	0.0	0.0	0.0	0.5	1.9	2.8	6.3	8.1	8.0	7.6	7.9	0.2	0.3
Total Cash & ST Investments		48.5	52.2	49.8	58.0	62.5	52.0	46.3	34.4	26.3	25.7	27.0	17.4	2.7	1.9
Accounts Receivable		12.0	10.6	12.2	13.3	5.1	4.6	7.3	4.2	3.8	3.8	3.9	2.0	2.0	1.6
Inventory		12.1	10.4	12.8	5.4	4.3	3.9	3.6	4.1	4.2	3.9	2.4	2.1	1.3	1.4
Other Current Assets		1.0	2.0	1.2	0.6	1.0	0.8	0.4	0.5	0.6	0.4	0.3	0.3	0.1	0.1
Total Current Assets		73.6	75.2	76.0	78.2	76.2	63.7	59.0	44.5	35.1	34.2	34.0	22.2	6.4	5.0

Current Assets		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents		56.5	53.0	50.3	52.2	51.7	48.5	45.1	49.8	46.7	45.8
Short Term Investments		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Cash & ST Investments		56.5	53.0	50.3	52.2	51.7	48.5	45.1	49.8	46.7	45.8
Accounts Receivable		13.9	10.9	12.7	10.6	10.4	12.0	13.0	12.2	12.8	11.1
Inventory		11.7	11.2	10.6	10.4	11.3	12.1	12.7	12.8	11.7	8.4
Other Current Assets		2.8	2.3	1.5	2.0	0.9	1.0	1.0	1.2	0.7	0.8
Total Current Assets		84.9	77.4	75.1	75.2	74.3	73.6	71.9	76.0	71.9	66.1

Long-Term Assets		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Property, Plant & Equipment		10.8	17.0	11.3	2.4	4.6	4.8	5.0	1.9	1.9	1.5	0.9	0.8	0.3	0.3
Goodwill		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets		2.7	3.1	2.5	2.1	1.1	1.0	0.9	0.8	0.9	0.9	0.2	0.3	0.3	0.3
Long-Term Investments		-5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets		5.5	0.2	0.2	2.2	0.2	0.3	0.2	0.1	0.2	0.2	0.1	0.0	0.0	0.0
Total Long-Term Assets		16.4	23.1	16.2	7.3	6.6	7.3	7.8	3.9	3.9	3.0	1.3	1.1	0.6	0.6
Total Assets		89.9	98.3	92.2	85.5	82.9	71.1	66.7	48.4	39.0	37.2	35.2	23.3	7.0	5.6

Long-Term Assets		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment		23.8	22.9	20.4	17.0	14.4	10.8	11.4	11.3	8.9	11.0
Goodwill		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets		3.4	3.4	3.3	3.1	2.9	2.7	2.7	2.5	2.5	2.4
Long-Term Investments		0.0	0.0	0.0	0.0	0.0	0.0	0.0	-4.6	-4.3	-4.1
Other Long-Term Assets		0.2	0.2	0.2	0.2	0.2	0.2	0.2	4.8	6.6	4.4
Total Long-Term Assets		29.8	29.1	26.6	23.1	20.0	16.4	16.1	16.2	15.5	15.3
Total Assets		114.7	106.4	101.7	98.3	94.2	89.9	88.0	92.2	87.4	81.4

Current Liabilities		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Accounts Payable		1.1	1.9	1.9	1.8	0.8	0.7	1.0	0.8	0.7	1.1	1.0	0.6	0.4	0.4
Short-Term Debt		0.4	0.2	0.9	0.3	0.3	0.3	0.2	0.1	1.7	1.4	0.0	0.1	0.0	0.5
Other Current Liabilities		3.4	4.0	10.7	3.1	3.2	2.1	3.0	2.0	0.1	0.1	1.3	1.3	0.8	1.0
Current Liabilities		7.5	8.5	16.3	8.6	6.8	4.9	5.9	4.7	4.1	3.7	2.9	2.3	1.5	2.3

Current Liabilities		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable		2.3	1.9	2.6	1.9	1.4	1.1	1.3	1.9	2.8	2.6
Short-Term Debt		0.0	0.0	0.1	0.2	0.3	0.4	0.4	0.9	0.8	0.8
Other Current Liabilities		7.3	3.3	2.6	4.0	3.7	3.3	2.5	10.7	2.2	2.3
Current Liabilities		12.8	8.8	8.5	8.5	8.1	7.5	7.6	16.3	7.9	7.6

Long-Term Liabilities		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Long-Term Debt		0.0	0.0	3.2	1.9	2.2	2.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Leases		0.0	0.2	2.0	2.2	2.5	2.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
Total Liabilities		10.3	11.5	20.7	11.8	10.7	9.7	11.2	6.5	6.1	5.3	3.3	2.4	1.6	2.3

Long-Term Liabilities		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt		0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.2	3.4	3.7
Capital Leases		0.0	0.0	0.1	0.2	0.3	0.4	1.9	1.6	2.1	2.2
Def. Tax Liability		0.0	0.0	0.0	0.0	0.0	0.0	0.0	-4.4	-3.2	-4.8
Total Liabilities		16.4	12.1	11.7	11.5	10.8	10.3	11.9	20.7	12.8	12.4

Total Common Equity		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Common Stock		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings		50.4	56.8	43.3	47.3	47.0	37.7	36.3	26.7	20.4	19.9	12.7	5.1	3.1	1.1
Comprehensive Income		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.1	0.0	0.0	0.0
Total Common Equity		79.7	86.8	71.4	73.7	72.2	61.4	55.5	41.9	32.9	31.9	31.9	20.9	5.4	3.2

Total Common Equity		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings		66.3	62.9	59.3	56.8	53.5	50.4	47.4	43.3	46.7	41.6
Comprehensive Income		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Common Equity		98.4	94.3	90.1	86.8	83.4	79.7	76.1	71.4	74.6	69.0

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Total Debt		0.4	0.2	2.0	2.2	2.5	2.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5
Book Value		79.7	86.8	71.4	73.7	72.2	61.4	55.5	41.9	32.9	31.9	31.9	20.9	5.4	3.2

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		98.4	94.3	90.1	86.8	83.4	79.7	76.1	71.4	74.6	69.0

Cash Flow From Operating Activities		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Income		18.6	22.5	19.2	17.2	12.8	9.3	1.4	9.6	6.3	0.5	7.2	7.5	2.1	1.9	1.0
Depreciation & Amortization		0.8	1.2	0.8	0.8	0.7	1.4	1.3	1.2	1.1	1.3	0.2	0.2	0.1	0.1	0.1
Stock-Based Compensation		2.3	2.9	2.5	2.2	1.4	1.5	4.0	1.9	1.8	2.5	1.8	1.2	0.7	0.3	0.2
Change Working Capital		-5.3	-4.3	3.7	-5.9	-5.1	-1.6	-1.2	-2.0	-1.8	-1.1	0.5	0.3	-0.4	-0.9	0.3
Change In Accounts Receivable		-0.9	-3.0	1.8	0.8	-8.2	-0.6	2.7	-3.1	-0.4	-0.2	0.1	-1.9	0.0	-0.4	-1.2
Change In Accounts Payable		-2.7	-0.1	-0.9	-0.2	1.1	0.0	-0.4	0.1	0.0	-0.5	0.0	0.4	0.2	0.0	0.3
Change In Inventories		-2.7	-1.4	3.1	0.0	-1.3	-0.4	-0.3	0.1	-0.1	-0.3	-1.5	-0.3	-0.8	0.0	-0.1
Other Non-cash Items		2.2	2.7	0.0	0.4	0.1	0.1	-0.1	0.1	0.2	0.4	570,909.6	-1.6	0.2	0.0	0.0
Cash from Operations		15.8	0.0	0.0	13.5	10.0	11.3	5.8	10.2	7.4	3.4	9.4	7.6	2.6	1.5	1.5

Cash Flow From Operating Activities		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income		6.4	5.6	5.8	4.7	5.1	5.0	4.9	4.1	4.5	5.1
Depreciation & Amortization		0.4	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
Stock-Based Compensation		0.7	0.0	0.7	0.8	0.7	0.6	0.6	0.6	0.6	0.5
Change Working Capital		-3.9	0.2	0.9	-1.5	0.2	3.1	2.4	-2.0	-1.3	-4.4
Change In Accounts Receivable		0.2	-2.9	1.8	-2.1	-0.2	1.7	1.0	-0.8	0.5	-1.7
Change In Accounts Payable		-0.5	0.4	-0.7	0.7	-0.4	0.3	-0.1	-0.6	-0.7	-1.2
Change In Inventories		0.1	-0.6	-0.8	-0.1	1.8	0.7	0.5	0.1	-1.3	-1.9
Other Non-cash Items		2.2	0.7	0.0	0.1	-0.1	0.0	0.1	0.0	0.0	0.0
Cash from Operations		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.4

Cash Flow From Investing Activities		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Capital Expenditure		-2.8	-7.8	-8.0	-7.4	-1.9	-0.7	-0.6	-0.5	-0.3	-0.8	-1.5	-0.3	-0.6	-0.2	-0.2
Acquisitions		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0
Investments		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-1.1	-2.7	-5.0	0.0	-8.0	0.0	0.0
Sales of Investment		0.0	0.0	0.0	0.0	0.5	1.4	0.9	3.7	2.9	2.5	4.6	0.3	0.3	0.0	0.0
Other Investing Activities		-0.4	0.0	0.0	-0.6	0.0	0.0	0.0	0.0	0.0	0.0	-0.7	0.0	0.0	0.0	0.0
Cash from Investing		-2.8	0.0	0.0	-8.0	-1.4	0.6	0.2	3.2	1.5	-1.0	-1.9	-0.1	-8.3	-0.2	-0.2

Cash Flow From Investing Activities		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure		-0.3	-1.3	-2.6	-3.7	-2.8	-3.8	-1.1	-0.3	-0.6	-0.4
Acquisitions		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Investments		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Sales of Investment		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Investing Activities		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.1	-0.1
Cash from Investing		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.6	-0.4

Cash Flow From Financing Activities		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Debt Repaid		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.5	-0.2
Debt Issued		-1.9	0.2	-1.9	-0.2	-0.3	-0.2	-0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8
Issuance of Common Stock		0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0
Repurchase of Common Stock		-0.5	0.0	0.0	-0.6	0.0	0.0	0.0	0.0	0.0	-1.8	-10.0	0.0	0.0	0.0	0.0
Dividends Paid		-23.1	0.0	0.0	-13.2	-12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities		0.0	0.0	0.0	-0.4	-0.1	0.0	0.5	2.0	0.9	-0.1	0.9	2.3	-1.8	0.0	0.0
Cash from Financing		-10.3	0.0	0.0	-13.7	-12.7	0.0	0.5	2.0	0.9	-1.9	-9.1	2.3	12.7	-0.5	-0.2

Cash Flow From Financing Activities		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued		0.0	0.0	-0.1	-0.1	-0.1	-0.1	-1.6	-0.1	-0.1	-0.1
Issuance of Common Stock		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
Repurchase of Common Stock		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-13.2	0.0
Other Financing Activities		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.4	0.0
Cash from Financing		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.3	0.0

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Change in Cash		2.7	-1.1	2.5	-8.2	-4.0	11.9	6.6	15.5	9.8	0.5	-1.7	9.9	7.0	0.8	1.1
Closing Cash Balance		48.5	51.2	52.2	49.8	58.0	62.0	50.1	43.5	28.0	18.2	17.7	19.4	9.5	2.5	1.7

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		-5.4	3.5	2.7	-1.9	0.5	3.2	3.4	-4.6	3.0	0.9
Closing Cash Balance		51.2	56.5	53.0	50.3	52.2	51.7	48.5	45.1	49.8	46.7

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Free Cash Flow		13.0	17.2	17.6	5.5	8.2	10.5	5.2	9.7	7.1	2.6	7.9	7.3	2.0	1.3	1.3
Real Free Cash Flow		10.7	14.3	15.1	3.3	6.8	9.1	1.2	7.9	5.3	0.1	6.0	6.1	1.3	1.0	1.2

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		5.4	5.8	4.9	0.6	2.9	5.1	5.4	3.4	3.3	1.0
Real Free Cash Flow		4.7	5.8	4.2	-0.2	2.3	4.5	4.8	2.8	2.7	0.4

Akciový screener

Kalendář zisků

Super investoři

Porovnání akcií